Jeffrey A. Wickersham,

An authority in the field of infectious diseases, Dr. Jeffrey A. Wickersham serves as an Assistant Professor of Medicine at Yale School of Medicine. With a profound commitment to advancing public health, his research is centered on enhancing HIV treatment and prevention strategies, particularly among sexual and gender minorities. Dr. Wickersham's work is pivotal in addressing the unique challenges faced by transgender women, gay men, and bisexual men in accessing effective healthcare solutions. Dr. Wickersham's innovative research encompasses both biomedical and behavioral interventions. He has been instrumental in exploring the efficacy of peer and patient navigation systems, which aim to improve healthcare access and adherence among marginalized communities. His work in implementing pre-exposure prophylaxis (PrEP) has been groundbreaking, providing vital insights into its adoption and effectiveness in diverse populations. In addition to his focus on PrEP, Dr. Wickersham is at the forefront of integrating technology into healthcare solutions. He has been involved in the development of AI-based "chatbot" technology, which offers personalized health information and support to individuals at risk of HIV. Furthermore, his efforts in adapting mobile health (mHealth) applications have significantly contributed to making healthcare more accessible and user-friendly for those in need. Dr. Wickersham's research is predominantly conducted in Southeast Asia, with a particular emphasis on Malaysia and Thailand. His work in these regions not only addresses local public health challenges but also contributes to the global understanding of HIV prevention and treatment. Through his dedication and expertise, Dr. Wickersham continues to make substantial contributions to the field of infectious diseases, striving to improve health outcomes for LGBTQ+ communities worldwide.